Media
Media
Our latest press releases
The Scottish Medicines Consortium (SMC) recommends use of Hansa Biopharma’s Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients
Regulatory press release
12/09/2022
Hansa Biopharma: Issue and repurchase of class C shares for incentive programs
Regulatory press release
09/09/2022
Hansa Biopharma and Medison Pharma announce positive reimbursement decision in Poland for Idefirix® in highly sensitized kidney transplant patients
22/08/2022
European Society for Organ Transplantation’s (ESOT) guidelines for desensitization treatment of highly sensitized kidney transplant patients published in Transplant International
10/08/2022
Media
News and insights
Patient stories
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Employee stories
Working in an epicentre of pioneering innovation
“The key to our collective success at Hansa Biopharma goes far beyond our scientific breakthroughs, as it stems from the amazing team spirit we have built.”
Patient stories
Taking care of a transplanted kidney through physical and mental health
“And people say to me: I never would have guessed that you had a kidney transplant… when I hear those words, they keep me motivated, and keep me going.”
Patient stories
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
Meetings of interest
Impactful interaction with the scientific and medical community
At Hansa, we are focused on the bigger picture and want help rare disease patients live long and healthy lives. We do this also by constant engagement with the scientific and healthcare communities. We use this opportunity to not only raise awareness about the unmet needs of the patients, but also to help advance the understanding in these complex fields. Meetings of interest